{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:34:06Z","timestamp":1778726046384,"version":"3.51.4"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Liver damage caused by toxicity can lead to various severe conditions, such as acute liver failure (ALF), fibrogenesis, and cirrhosis. Among these, liver cirrhosis (LC) is recognized as the leading cause of liver-related deaths globally. Unfortunately, patients with progressive cirrhosis are often on a waiting list, with limited donor organs, postoperative complications, immune system side effects, and high financial costs being some of the factors restricting transplantation. Although the liver has some capacity for self-renewal due to the presence of stem cells, it is usually insufficient to prevent the progression of LC and ALF. One potential therapeutic approach to improving liver function is the transplantation of gene-engineered stem cells. Several types of mesenchymal stem cells from various sources have been suggested for stem cell therapy for liver disease. Genetic engineering is an effective strategy that enhances the regenerative potential of stem cells by releasing growth factors and cytokines. In this review, we primarily focus on the genetic engineering of stem cells to improve their ability to treat damaged liver function. We also recommend further research into accurate treatment methods that involve safe gene modification and long-term follow-up of patients to increase the effectiveness and reliability of these therapeutic strategies.<\/jats:p>","DOI":"10.1186\/s13287-023-03364-x","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T12:02:22Z","timestamp":1684929742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Potential advantages of genetically modified mesenchymal stem cells in the treatment of acute and chronic liver diseases"],"prefix":"10.1186","volume":"14","author":[{"given":"Farnaz","family":"Sani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Sani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Moayedfard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Darayee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lobat","family":"Tayebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5549-0057","authenticated-orcid":false,"given":"Negar","family":"Azarpira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"issue":"10159","key":"3364_CR1","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"GA Roth","year":"2018","unstructured":"Roth GA, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736\u201388.","journal-title":"Lancet"},{"issue":"1","key":"3364_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0159-5","volume":"12","author":"P Byass","year":"2014","unstructured":"Byass P. The global burden of liver disease: a challenge for methods and for public health. BMC Med. 2014;12(1):1\u20133.","journal-title":"BMC Med"},{"issue":"11","key":"3364_CR3","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1002\/stem.1818","volume":"32","author":"V Volarevic","year":"2014","unstructured":"Volarevic V, et al. Concise review: therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem cells. 2014;32(11):2818\u201323.","journal-title":"Stem cells"},{"issue":"3","key":"3364_CR4","first-page":"357","volume":"30","author":"SA Karageorgos","year":"2017","unstructured":"Karageorgos SA, et al. Long-term change in incidence and risk factors of cirrhosis and hepatocellular carcinoma in Crete, Greece: a 25-year study. Ann Gastroenterol. 2017;30(3):357.","journal-title":"Ann Gastroenterol"},{"issue":"8","key":"3364_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1056\/NEJMra1504367","volume":"375","author":"PS Ge","year":"2016","unstructured":"Ge PS, Runyon BA. Treatment of patients with cirrhosis. N Engl J Med. 2016;375(8):767\u201377.","journal-title":"N Engl J Med"},{"issue":"1","key":"3364_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S1499-3872(13)60007-7","volume":"12","author":"W Zhu","year":"2013","unstructured":"Zhu W, et al. Effects of xenogeneic adipose-derived stem cell transplantation on acute-on-chronic liver failure. Hepatobiliary Pancreat Dis Int. 2013;12(1):60\u20137.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"3364_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF02895597","volume":"19","author":"C Libo","year":"1999","unstructured":"Libo C, Zhen Y, Fazu Q. Studies on hepatocyte apoptosis, proliferation and oncogene c-fos expression in carbon tetrachloride-induced cirrhotic rat liver. J Tongji Med Univ. 1999;19(1):53\u20135.","journal-title":"J Tongji Med Univ"},{"issue":"28","key":"3364_CR8","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.2174\/092986712803341520","volume":"19","author":"V S\u00e1nchez-Valle","year":"2012","unstructured":"S\u00e1nchez-Valle V, et al. Role of oxidative stress and molecular changes in liver fibrosis: a review. Curr Med Chem. 2012;19(28):4850\u201360.","journal-title":"Curr Med Chem"},{"issue":"5","key":"3364_CR9","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.copbio.2009.09.004","volume":"20","author":"JW Kung","year":"2009","unstructured":"Kung JW, Forbes SJ. Stem cells and liver repair. Curr Opin Biotechnol. 2009;20(5):568\u201374.","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"3364_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jhep.2013.01.018","volume":"59","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Wang F-S. Stem cell therapies for liver failure and cirrhosis. J Hepatol. 2013;59(1):183\u20135.","journal-title":"J Hepatol"},{"issue":"3\u20134","key":"3364_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000369552","volume":"54","author":"R Gramignoli","year":"2015","unstructured":"Gramignoli R, et al. Clinical hepatocyte transplantation: practical limits and possible solutions. Eur Surg Res. 2015;54(3\u20134):162\u201377.","journal-title":"Eur Surg Res"},{"issue":"7","key":"3364_CR12","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/j.1478-3231.2010.02364.x","volume":"31","author":"KA Cho","year":"2011","unstructured":"Cho KA, et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Liver Int. 2011;31(7):932\u20139.","journal-title":"Liver Int"},{"key":"3364_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2782548","volume":"2019","author":"J AdiwinataPawitan","year":"2019","unstructured":"AdiwinataPawitan J. Exploring the most promising stem cell therapy in liver failure: a systematic review. Stem Cells Int. 2019;2019:1\u201315.","journal-title":"Stem Cells Int"},{"key":"3364_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4197857","volume":"2018","author":"K-A Kwak","year":"2018","unstructured":"Kwak K-A, et al. Current perspectives regarding stem cell-based therapy for liver cirrhosis. Can J Gastroenterol Hepatol. 2018;2018:1\u201319.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"5","key":"3364_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00535-012-0580-5","volume":"47","author":"S Terai","year":"2012","unstructured":"Terai S, et al. Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy. J Gastroenterol. 2012;47(5):491\u20137.","journal-title":"J Gastroenterol"},{"issue":"10","key":"3364_CR16","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/MEG.0b013e3283488b00","volume":"23","author":"M-EM Amer","year":"2011","unstructured":"Amer M-EM, et al. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells. Eur J Gastroenterol Hepatol. 2011;23(10):936\u201341.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"3364_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1089\/ten.teb.2013.0527","volume":"20","author":"S Terai","year":"2014","unstructured":"Terai S, et al. Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells. Tissue Eng Part B Rev. 2014;20(3):206\u201310.","journal-title":"Tissue Eng Part B Rev"},{"issue":"1","key":"3364_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-020-00480-6","volume":"10","author":"X Yang","year":"2020","unstructured":"Yang X, et al. Mesenchymal stem cell therapy for liver disease: full of chances and challenges. Cell Biosci. 2020;10(1):1\u201318.","journal-title":"Cell Biosci"},{"issue":"1","key":"3364_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/hep.23354","volume":"51","author":"K Si-Tayeb","year":"2010","unstructured":"Si-Tayeb K, et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology. 2010;51(1):297\u2013305.","journal-title":"Hepatology"},{"issue":"34","key":"3364_CR20","doi-asserted-by":"publisher","first-page":"12301","DOI":"10.1073\/pnas.0806522105","volume":"105","author":"DC Hay","year":"2008","unstructured":"Hay DC, et al. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci. 2008;105(34):12301\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"3364_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cellimm.2017.07.010","volume":"326","author":"L Lin","year":"2018","unstructured":"Lin L, Du L. The role of secreted factors in stem cells-mediated immune regulation. Cell Immunol. 2018;326:24\u201332.","journal-title":"Cell Immunol"},{"issue":"40","key":"3364_CR22","doi-asserted-by":"publisher","first-page":"14884","DOI":"10.3748\/wjg.v20.i40.14884","volume":"20","author":"H-C Ma","year":"2014","unstructured":"Ma H-C, et al. Targeted migration of mesenchymal stem cells modified with CXCR4 to acute failing liver improves liver regeneration. World J Gastroenterol WJG. 2014;20(40):14884.","journal-title":"World J Gastroenterol WJG"},{"issue":"43","key":"3364_CR23","doi-asserted-by":"publisher","first-page":"37222","DOI":"10.1074\/jbc.M111.294116","volume":"286","author":"C Delgado-Mart\u00edn","year":"2011","unstructured":"Delgado-Mart\u00edn C, et al. Chemokine CXCL12 uses CXCR4 and a signaling core formed by bifunctional Akt, extracellular signal-regulated kinase (ERK) 1\/2, and mammalian target of rapamycin complex 1 (mTORC1) proteins to control chemotaxis and survival simultaneously in mature dendritic cells. J Biol Chem. 2011;286(43):37222\u201336.","journal-title":"J Biol Chem"},{"key":"3364_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fimmu.2015.00429","volume":"6","author":"L Pawig","year":"2015","unstructured":"Pawig L, et al. Diversity and inter-connections in the CXCR4 chemokine receptor\/ligand family: molecular perspectives. Front Immunol. 2015;6:429.","journal-title":"Front Immunol"},{"issue":"52","key":"3364_CR25","doi-asserted-by":"publisher","first-page":"18117","DOI":"10.1073\/pnas.0408258102","volume":"101","author":"J Imitola","year":"2004","unstructured":"Imitola J, et al. Directed migrationof neural stem cellsto sites of CNS injury by thestromal cell-derived factor1\u03b1\/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci. 2004;101(52):18117\u201322.","journal-title":"Proc Natl Acad Sci"},{"key":"3364_CR26","first-page":"212","volume":"5","author":"Y D\u00f6ring","year":"2014","unstructured":"D\u00f6ring Y, et al. The CXCL12\/CXCR4 chemokine ligand\/receptor axis in cardiovascular disease. Front Physiol. 2014;5:212.","journal-title":"Front Physiol"},{"issue":"13","key":"3364_CR27","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1073\/pnas.0306068101","volume":"101","author":"C-G Huh","year":"2004","unstructured":"Huh C-G, et al. Hepatocyte growth factor\/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci. 2004;101(13):4477\u201382.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"3364_CR28","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.freeradbiomed.2009.05.014","volume":"47","author":"A Vald\u00e9s-Arzate","year":"2009","unstructured":"Vald\u00e9s-Arzate A, et al. Hepatocyte growth factor protects hepatocytes against oxidative injury induced by ethanol metabolism. Free Radic Biol Med. 2009;47(4):424\u201330.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"3364_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/BF03401777","volume":"6","author":"D Phaneuf","year":"2000","unstructured":"Phaneuf D, Chen S-J, Wilson JM. Intravenous injection of an adenovirus encoding hepatocyte growth factor results in liver growth and has a protective effect against apoptosis. Mol Med. 2000;6(2):96\u2013103.","journal-title":"Mol Med"},{"issue":"2","key":"3364_CR30","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jhep.2013.09.009","volume":"60","author":"S Giordano","year":"2014","unstructured":"Giordano S, Columbano A. Met as a therapeutic target in HCC: facts and hopes. J Hepatol. 2014;60(2):442\u201352.","journal-title":"J Hepatol"},{"key":"3364_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fcell.2020.00055","volume":"8","author":"H Wang","year":"2020","unstructured":"Wang H, et al. The function of the HGF\/c-Met axis in hepatocellular carcinoma. Front Cell Dev Biol. 2020;8:55.","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"3364_CR32","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0962-8924(98)01359-2","volume":"8","author":"C Birchmeier","year":"1998","unstructured":"Birchmeier C, Gherardi E. Developmental roles of HGF\/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol. 1998;8(10):404\u201310.","journal-title":"Trends Cell Biol"},{"issue":"4","key":"3364_CR33","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s10620-012-2052-4","volume":"57","author":"C Zhu","year":"2012","unstructured":"Zhu C, et al. Gene transfer of c-met confers protection against D-galactosamine\/lipopolysaccharide-induced acute liver failure. Dig Dis Sci. 2012;57(4):925\u201334.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"3364_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-017-0614-2","volume":"8","author":"K Wang","year":"2017","unstructured":"Wang K, et al. Overexpression of c-Met in bone marrow mesenchymal stem cells improves their effectiveness in homing and repair of acute liver failure. Stem Cell Res Ther. 2017;8(1):1\u201310.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"3364_CR35","doi-asserted-by":"publisher","first-page":"626","DOI":"10.7150\/ijms.8228","volume":"11","author":"J Liu","year":"2014","unstructured":"Liu J, et al. HGF\/c-Met signaling mediated mesenchymal stem cell-induced liver recovery in intestinal ischemia reperfusion model. Int J Med Sci. 2014;11(6):626.","journal-title":"Int J Med Sci"},{"issue":"11","key":"3364_CR36","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/nm1307","volume":"11","author":"J Chen","year":"2005","unstructured":"Chen J, et al. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med. 2005;11(11):1188\u201396.","journal-title":"Nat Med"},{"issue":"4","key":"3364_CR37","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/sj.leu.2402090","volume":"15","author":"P Ruvolo","year":"2001","unstructured":"Ruvolo P, Deng X, May W. Phosphorylation of Bcl2 and regulation of apoptosis. Leukemia. 2001;15(4):515\u201322.","journal-title":"Leukemia"},{"key":"3364_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-94-007-6262-6_4","volume-title":"Stem cells and cancer stem cells","author":"W Chang","year":"2013","unstructured":"Chang W, Song B-W, Hwang K-C. Mesenchymal stem cell survival in infarcted myocardium: adhesion and anti-death signals. In: Haya MA, editor. Stem cells and cancer stem cells, vol. 10. Springer; 2013. p. 35\u201343."},{"issue":"1","key":"3364_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5966\/sctm.2016-0038","volume":"6","author":"J Ma","year":"2017","unstructured":"Ma J, et al. Exosomes derived from AKt-modified human umbilical cord mesenchymal stem cells improve cardiac regeneration and promote angiogenesis via activating platelet-derived growth factor D. Stem Cells Transl Med. 2017;6(1):51\u20139.","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"3364_CR40","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1053\/j.gastro.2004.07.019","volume":"127","author":"T Takehara","year":"2004","unstructured":"Takehara T, et al. Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. Gastroenterology. 2004;127(4):1189\u201397.","journal-title":"Gastroenterology"},{"issue":"3","key":"3364_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/path.1711580314","volume":"158","author":"DJ Pritchard","year":"1989","unstructured":"Pritchard DJ, Butler WH. Apoptosis\u2014the mechanism of cell death in dimethylnitrosamine-induced hepatotoxicity. J Pathol. 1989;158(3):253\u201360.","journal-title":"J Pathol"},{"issue":"2","key":"3364_CR42","first-page":"39","volume":"2","author":"G Yan","year":"2020","unstructured":"Yan G, Elbadawi M, Efferth T. Multiple cell death modalities and their key features. World Acad Sci J. 2020;2(2):39\u201348.","journal-title":"World Acad Sci J"},{"issue":"2","key":"3364_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4161\/cbt.4.2.1508","volume":"4","author":"Z Jin","year":"2005","unstructured":"Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther. 2005;4(2):147\u201371.","journal-title":"Cancer Biol Ther"},{"issue":"5684","key":"3364_CR44","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1126\/science.1099320","volume":"305","author":"DR Green","year":"2004","unstructured":"Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science. 2004;305(5684):626\u20139.","journal-title":"Science"},{"issue":"2","key":"3364_CR45","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1523\/JNEUROSCI.16-02-00486.1996","volume":"16","author":"MS Lawrence","year":"1996","unstructured":"Lawrence MS, et al. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosci. 1996;16(2):486\u201396.","journal-title":"J Neurosci"},{"issue":"14","key":"3364_CR46","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/sj.gt.3301211","volume":"7","author":"K Shimazaki","year":"2000","unstructured":"Shimazaki K, et al. Adeno-associated virus vector-mediated bcl-2 gene transfer into post-ischemic gerbil brain in vivo: prospects for gene therapy of ischemia-induced neuronal death. Gene Ther. 2000;7(14):1244\u20139.","journal-title":"Gene Ther"},{"issue":"5","key":"3364_CR47","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1159\/000453166","volume":"40","author":"S Jin","year":"2016","unstructured":"Jin S, et al. Mesenchymal stem cells with enhanced Bcl-2 expression promote liver recovery in a rat model of hepatic cirrhosis. Cell Physiol Biochem. 2016;40(5):1117\u201328.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"3364_CR48","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1074\/jbc.275.2.1226","volume":"275","author":"A Garcia-Oca\u00f1a","year":"2000","unstructured":"Garcia-Oca\u00f1a A, et al. Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J Biol Chem. 2000;275(2):1226\u201332.","journal-title":"J Biol Chem"},{"issue":"6248","key":"3364_CR49","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/342440a0","volume":"342","author":"T Nakamura","year":"1989","unstructured":"Nakamura T, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989;342(6248):440\u20133.","journal-title":"Nature"},{"key":"3364_CR50","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1440-1746.2010.06549.x","volume":"26","author":"T Nakamura","year":"2011","unstructured":"Nakamura T, et al. Hepatocyte growth factor twenty years on: much more than a growth factor. J Gastroenterol Hepatol. 2011;26:188\u2013202.","journal-title":"J Gastroenterol Hepatol"},{"key":"3364_CR51","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3389\/fendo.2018.00503","volume":"9","author":"AG Oliveira","year":"2018","unstructured":"Oliveira AG, et al. The role of hepatocyte growth factor (HGF) in insulin resistance and diabetes. Front Endocrinol. 2018;9:503.","journal-title":"Front Endocrinol"},{"issue":"4","key":"3364_CR52","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/oxfordjournals.jbchem.a021283","volume":"119","author":"K Matsumoto","year":"1996","unstructured":"Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem. 1996;119(4):591\u2013600.","journal-title":"J Biochem"},{"issue":"4995","key":"3364_CR53","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1126\/science.1846706","volume":"251","author":"DP Bottaro","year":"1991","unstructured":"Bottaro DP, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 1991;251(4995):802\u20134.","journal-title":"Science"},{"issue":"4","key":"3364_CR54","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/biomedicines2040275","volume":"2","author":"K Matsumoto","year":"2014","unstructured":"Matsumoto K, et al. HGF\u2013Met pathway in regeneration and drug discovery. Biomedicines. 2014;2(4):275\u2013300.","journal-title":"Biomedicines"},{"issue":"7","key":"3364_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-0747-y","volume":"9","author":"I Martins","year":"2018","unstructured":"Martins I, et al. Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death. Cell Death Dis. 2018;9(7):1\u201318.","journal-title":"Cell Death Dis"},{"key":"3364_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/5452487","volume":"2016","author":"Y Tang","year":"2016","unstructured":"Tang Y, et al. Therapeutic potential of HGF-expressing human umbilical cord mesenchymal stem cells in mice with acute liver failure. Int J Hepatol. 2016;2016:1\u201313.","journal-title":"Int J Hepatol"},{"issue":"3","key":"3364_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2001-2-3-reviews3005","volume":"2","author":"DM Ornitz","year":"2001","unstructured":"Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol. 2001;2(3):1\u201312.","journal-title":"Genome Biol"},{"key":"3364_CR58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fcell.2020.00079","volume":"8","author":"M Mossahebi-Mohammadi","year":"2020","unstructured":"Mossahebi-Mohammadi M, et al. FGF signaling pathway: a key regulator of stem cell pluripotency. Front Cell Dev Biol. 2020;8:79.","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"3364_CR59","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/ajh.21030","volume":"82","author":"L Yan","year":"2007","unstructured":"Yan L, et al. Peripheral blood monocytes from patients with HBV related decompensated liver cirrhosis can differentiate into functional hepatocytes. Am J Hematol. 2007;82(11):949\u201354.","journal-title":"Am J Hematol"},{"issue":"8","key":"3364_CR60","first-page":"12774","volume":"8","author":"J Wang","year":"2015","unstructured":"Wang J, et al. Bone mesenchymal stem cells overexpressing FGF4 contribute to liver regeneration in an animal model of liver cirrhosis. Int J Clin Exp Med. 2015;8(8):12774.","journal-title":"Int J Clin Exp Med"},{"issue":"7","key":"3364_CR61","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1478-3231.2010.02428.x","volume":"31","author":"K Bonefeld","year":"2011","unstructured":"Bonefeld K, M\u00f8ller S. Insulin-like growth factor-I and the liver. Liver Int. 2011;31(7):911\u20139.","journal-title":"Liver Int"},{"issue":"2","key":"3364_CR62","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ecl.2012.04.017","volume":"41","author":"DR Clemmons","year":"2012","unstructured":"Clemmons DR. Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin. 2012;41(2):425\u201343.","journal-title":"Endocrinol Metab Clin"},{"issue":"6","key":"3364_CR63","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1089\/scd.2014.0174","volume":"24","author":"EJ Fiore","year":"2015","unstructured":"Fiore EJ, et al. Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice. Stem Cells Dev. 2015;24(6):791\u2013801.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"3364_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-016-0424-y","volume":"7","author":"E Fiore","year":"2016","unstructured":"Fiore E, et al. Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells. Stem Cell Res Ther. 2016;7(1):1\u201314.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"3364_CR65","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1742-4658.2012.08565.x","volume":"280","author":"P Rios","year":"2013","unstructured":"Rios P, Li X, K\u00f6hn M. Molecular mechanisms of the PRL phosphatases. FEBS J. 2013;280(2):505\u201324.","journal-title":"FEBS J"},{"issue":"27","key":"3364_CR66","doi-asserted-by":"publisher","first-page":"17286","DOI":"10.1074\/jbc.273.27.17286","volume":"273","author":"Y Peng","year":"1998","unstructured":"Peng Y, et al. The gene encoding human nuclear protein tyrosine phosphatase, PRL-1: cloning, chromosomal localization, and identification of an intron enhancer. J Biol Chem. 1998;273(27):17286\u201395.","journal-title":"J Biol Chem"},{"issue":"12","key":"3364_CR67","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1369\/jhc.6A7019.2006","volume":"54","author":"CM Dumaual","year":"2006","unstructured":"Dumaual CM, et al. Cellular localization of PRL-1 and PRL-2 gene expression in normal adult human tissues. J Histochem Cytochem. 2006;54(12):1401\u201312.","journal-title":"J Histochem Cytochem"},{"issue":"7","key":"3364_CR68","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/onc.2011.281","volume":"31","author":"Y Wang","year":"2012","unstructured":"Wang Y, Lazo JS. Metastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion. Oncogene. 2012;31(7):818\u201327.","journal-title":"Oncogene"},{"issue":"1\u20132","key":"3364_CR69","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3835(96)04459-X","volume":"110","author":"CA Cates","year":"1996","unstructured":"Cates CA, et al. Prenylation of oncogenic humanPTPCAAXprotein tyrosine phosphatases. Cancer Lett. 1996;110(1\u20132):49\u201355.","journal-title":"Cancer Lett"},{"issue":"10","key":"3364_CR70","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1111\/j.1349-7006.2010.01651.x","volume":"101","author":"S Semba","year":"2010","unstructured":"Semba S, Mizuuchi E, Yokozaki H. Requirement of phosphatase of regenerating liver-3 for the nucleolar localization of nucleolin during the progression of colorectal carcinoma. Cancer Sci. 2010;101(10):2254\u201361.","journal-title":"Cancer Sci"},{"issue":"6","key":"3364_CR71","first-page":"3752","volume":"14","author":"RH Diamond","year":"1994","unstructured":"Diamond RH, et al. PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol Cell Biol. 1994;14(6):3752\u201362.","journal-title":"Mol Cell Biol"},{"issue":"8","key":"3364_CR72","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1021\/bi8020789","volume":"48","author":"Y Luo","year":"2009","unstructured":"Luo Y, Liang F, Zhang Z-Y. PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1\/2 pathways. Biochemistry. 2009;48(8):1838\u201346.","journal-title":"Biochemistry"},{"issue":"1","key":"3364_CR73","doi-asserted-by":"publisher","first-page":"G121","DOI":"10.1152\/ajpgi.1996.271.1.G121","volume":"271","author":"RH Diamond","year":"1996","unstructured":"Diamond RH, et al. Expression of PRL-1 nuclear PTPase is associated with proliferation in liver but with differentiation in intestine. Am J Physiol Gastrointest Liver Physiol. 1996;271(1):G121\u20139.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"3364_CR74","doi-asserted-by":"publisher","first-page":"G85","DOI":"10.1152\/ajpgi.00084.2014","volume":"308","author":"Y Jiao","year":"2015","unstructured":"Jiao Y, et al. Protein tyrosine phosphatase of liver regeneration-1 is required for normal timing of cell cycle progression during liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2015;308(2):G85\u201391.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"3364_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-02029-3","volume":"11","author":"JY Kim","year":"2020","unstructured":"Kim JY, et al. Enhanced PRL-1 expression in placenta-derived mesenchymal stem cells accelerates hepatic function via mitochondrial dynamics in a cirrhotic rat model. Stem Cell Res Ther. 2020;11(1):1\u201317.","journal-title":"Stem Cell Res Ther"},{"issue":"27","key":"3364_CR76","doi-asserted-by":"publisher","first-page":"6289","DOI":"10.1016\/j.febslet.2006.10.061","volume":"580","author":"S Perrier","year":"2006","unstructured":"Perrier S, Darakhshan F, Hajduch E. IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde? FEBS Lett. 2006;580(27):6289\u201394.","journal-title":"FEBS Lett"},{"issue":"1","key":"3364_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41232-019-0101-5","volume":"39","author":"N Kaneko","year":"2019","unstructured":"Kaneko N, et al. The role of interleukin-1 in general pathology. Inflamm Regen. 2019;39(1):1\u201316.","journal-title":"Inflamm Regen"},{"issue":"10","key":"3364_CR78","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1056\/NEJM200009073431011","volume":"343","author":"CA Dinarello","year":"2000","unstructured":"Dinarello CA. The role of the interleukin-1\u2013receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med. 2000;343(10):732\u20134.","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"3364_CR79","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000314592","volume":"83","author":"A Baranova","year":"2011","unstructured":"Baranova A, et al. Association of serum adipocytokines with hepatic steatosis and fibrosis in patients with chronic hepatitis C. Digestion. 2011;83(1\u20132):32\u201340.","journal-title":"Digestion"},{"issue":"9","key":"3364_CR80","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1634\/stemcells.2005-0590","volume":"24","author":"CC Sun","year":"2006","unstructured":"Sun CC, et al. Interleukin-1 receptor antagonist (IL-1RA) prevents apoptosis in ex vivo expansion of human limbal epithelial cells cultivated on human amniotic membrane. Stem Cells. 2006;24(9):2130\u20139.","journal-title":"Stem Cells"},{"issue":"9","key":"3364_CR81","doi-asserted-by":"publisher","first-page":"e25442","DOI":"10.1371\/journal.pone.0025442","volume":"6","author":"A Sgroi","year":"2011","unstructured":"Sgroi A, et al. Interleukin-1 receptor antagonist modulates the early phase of liver regeneration after partial hepatectomy in mice. PLoS ONE. 2011;6(9):e25442.","journal-title":"PLoS ONE"},{"issue":"7","key":"3364_CR82","doi-asserted-by":"publisher","first-page":"e41392","DOI":"10.1371\/journal.pone.0041392","volume":"7","author":"Y-B Zheng","year":"2012","unstructured":"Zheng Y-B, et al. Amniotic-fluid-derived mesenchymal stem cells overexpressing interleukin-1 receptor antagonist improve fulminant hepatic failure. PLoS ONE. 2012;7(7):e41392.","journal-title":"PLoS ONE"},{"issue":"6","key":"3364_CR83","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1053\/jhep.2003.50273","volume":"37","author":"AJ Watt","year":"2003","unstructured":"Watt AJ, Garrison WD, Duncan SA. HNF4: a central regulator of hepatocyte differentiation and function. Hepatology. 2003;37(6):1249\u201353.","journal-title":"Hepatology"},{"issue":"3","key":"3364_CR84","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/ng1175","volume":"34","author":"F Parviz","year":"2003","unstructured":"Parviz F, et al. Hepatocyte nuclear factor 4\u03b1 controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet. 2003;34(3):292\u20136.","journal-title":"Nat Genet"},{"issue":"5","key":"3364_CR85","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jhep.2017.11.026","volume":"68","author":"HH Lau","year":"2018","unstructured":"Lau HH, et al. The molecular functions of hepatocyte nuclear factors\u2014in and beyond the liver. J Hepatol. 2018;68(5):1033\u201348.","journal-title":"J Hepatol"},{"issue":"5","key":"3364_CR86","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.apsb.2016.07.003","volume":"6","author":"H Lu","year":"2016","unstructured":"Lu H. Crosstalk of HNF4\u03b1 with extracellular and intracellular signaling pathways in the regulation of hepatic metabolism of drugs and lipids. Acta Pharm Sin B. 2016;6(5):393\u2013408.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"3364_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1260-7","volume":"10","author":"Z Ye","year":"2019","unstructured":"Ye Z, et al. Mesenchymal stem cells overexpressing hepatocyte nuclear factor-4 alpha alleviate liver injury by modulating anti-inflammatory functions in mice. Stem Cell Res Ther. 2019;10(1):1\u201310.","journal-title":"Stem Cell Res Ther"},{"issue":"24","key":"3364_CR88","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1002\/1873-3468.14453","volume":"596","author":"Y Yu","year":"2022","unstructured":"Yu Y, Zhang Q, Wu N, Xia L, Cao J, Xia Q, Zhao J, Zhang J, Hang H. HNF4\u03b1 overexpression enhances the therapeutic potential of umbilical cord mesenchymal stem\/stromal cells in mice with acute liver failure. FEBS Lett. 2022;596(24):3176\u201390.","journal-title":"FEBS Lett."},{"issue":"1","key":"3364_CR89","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cyto.2008.04.007","volume":"43","author":"S Girard","year":"2008","unstructured":"Girard S, et al. Pro-inflammatory disequilibrium of theIL-1\u03b2\/IL-1ra ratio in an experimental model of perinatal brain damages induced by lipopolysaccharide andhypoxia\u2013ischemia. Cytokine. 2008;43(1):54\u201362.","journal-title":"Cytokine"},{"issue":"suppl_3","key":"3364_CR90","doi-asserted-by":"publisher","first-page":"iii2","DOI":"10.1093\/rheumatology\/keh201","volume":"43","author":"J Kay","year":"2004","unstructured":"Kay J, Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology. 2004;43(suppl_3):iii2\u20139.","journal-title":"Rheumatology"},{"issue":"3","key":"3364_CR91","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/labinvest.3700228","volume":"85","author":"K Tron","year":"2005","unstructured":"Tron K, et al. Upregulation of heme oxygenase-1 gene by turpentine oil-induced localized inflammation: involvement of interleukin-6. Lab Investig. 2005;85(3):376\u201387.","journal-title":"Lab Investig"},{"issue":"2","key":"3364_CR92","first-page":"260","volume":"15","author":"H Ma","year":"2016","unstructured":"Ma H, et al. IL-1\u03b2 siRNA adenovirus benefits liver regeneration by improving mesenchymal stem cells survival after acute liver failure. Ann Hepatol. 2016;15(2):260\u201370.","journal-title":"Ann Hepatol"},{"issue":"7791","key":"3364_CR93","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-019-1897-5","volume":"577","author":"J Su","year":"2020","unstructured":"Su J, et al. TGF-\u03b2 orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1. Nature. 2020;577(7791):566\u201371.","journal-title":"Nature"},{"issue":"10","key":"3364_CR94","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massagu\u00e9","year":"2012","unstructured":"Massagu\u00e9 J. TGF\u03b2 signalling in context. Nat Rev Mol Cell Biol. 2012;13(10):616\u201330.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"20","key":"3364_CR95","doi-asserted-by":"publisher","first-page":"17058","DOI":"10.1074\/jbc.M100754200","volume":"276","author":"F Verrecchia","year":"2001","unstructured":"Verrecchia F, Chu M-L, Mauviel A. Identification of novel TGF-\u03b2\/Smad gene targets in dermal fibroblasts using a combined cDNA microarray\/promoter transactivation approach. J Biol Chem. 2001;276(20):17058\u201362.","journal-title":"J Biol Chem"},{"issue":"26","key":"3364_CR96","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1038\/sj.onc.1204448","volume":"20","author":"F Verrecchia","year":"2001","unstructured":"Verrecchia F, et al. Smad3\/AP-1 interactions control transcriptional responses to TGF-\u03b2 in a promoter-specific manner. Oncogene. 2001;20(26):3332\u201340.","journal-title":"Oncogene"},{"issue":"11","key":"3364_CR97","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1093\/emboj\/17.11.3091","volume":"17","author":"S Dennler","year":"1998","unstructured":"Dennler S, et al. Direct binding of Smad3 and Smad4 to critical TGF\u03b2-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 1998;17(11):3091\u2013100.","journal-title":"EMBO J"},{"issue":"19","key":"3364_CR98","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1101\/gad.12.19.3084","volume":"12","author":"X Hua","year":"1998","unstructured":"Hua X, et al. Synergistic cooperation of TFE3 and smad proteins in TGF-\u03b2-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev. 1998;12(19):3084\u201395.","journal-title":"Genes Dev"},{"issue":"2","key":"3364_CR99","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/embor.2009.276","volume":"11","author":"C Margadant","year":"2010","unstructured":"Margadant C, Sonnenberg A. Integrin\u2013TGF-\u03b2 crosstalk in fibrosis, cancer and wound healing. EMBO Rep. 2010;11(2):97\u2013105.","journal-title":"EMBO Rep"},{"issue":"12","key":"3364_CR100","doi-asserted-by":"publisher","first-page":"7844","DOI":"10.1074\/jbc.M703125200","volume":"283","author":"H Dadlani","year":"2008","unstructured":"Dadlani H, et al. Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle. J Biol Chem. 2008;283(12):7844\u201352.","journal-title":"J Biol Chem"},{"issue":"1","key":"3364_CR101","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1042\/bj3100073","volume":"310","author":"M Romaris","year":"1995","unstructured":"Romaris M, Bassols A, David G. Effect of transforming growth factor-\u03b2 1 and basic fibroblast growth factor on the expression of cell surface proteoglycans in human lung fibroblasts. Enhanced glycanation and fibronectin-binding of CD44 proteoglycan, and down-regulation of glypican. Biochem J. 1995;310(1):73\u201381.","journal-title":"Biochem J"},{"issue":"42","key":"3364_CR102","doi-asserted-by":"publisher","first-page":"38502","DOI":"10.1074\/jbc.M107081200","volume":"276","author":"W Yuan","year":"2001","unstructured":"Yuan W, Varga J. Transforming growth factor-\u03b2 repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. J Biol Chem. 2001;276(42):38502\u201310.","journal-title":"J Biol Chem"},{"issue":"4","key":"3364_CR103","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/j.1523-1755.2002.kid567.x","volume":"62","author":"Y Chen","year":"2002","unstructured":"Chen Y, et al. CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int. 2002;62(4):1149\u201359.","journal-title":"Kidney Int"},{"key":"3364_CR104","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0016-5085(03)00666-8","volume":"125","author":"S Dooley","year":"2003","unstructured":"Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, Ten Dijke P, Gressner AM. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology. 2003;125:178\u201391.","journal-title":"Gastroenterology"},{"issue":"3","key":"3364_CR105","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.3892\/etm.2017.4836","volume":"14","author":"SP Wu","year":"2017","unstructured":"Wu SP, et al. Smad7-overexpressing rat BMSCs inhibit the fibrosis of hepatic stellate cells by regulating the TGF-\u03b21\/Smad signaling pathway. Exp Ther Med. 2017;14(3):2568\u201376.","journal-title":"Exp Ther Med"},{"issue":"1","key":"3364_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01911-4","volume":"11","author":"D-N Su","year":"2020","unstructured":"Su D-N, Wu S-P, Xu S-Z. Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis. Stem Cell Res Ther. 2020;11(1):1\u201311.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"3364_CR107","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215\u201333.","journal-title":"Cell"},{"issue":"6","key":"3364_CR108","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.cell.2012.02.005","volume":"148","author":"JT Mendell","year":"2012","unstructured":"Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell. 2012;148(6):1172\u201387.","journal-title":"Cell"},{"issue":"7224","key":"3364_CR109","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T Thum","year":"2008","unstructured":"Thum T, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 2008;456(7224):980\u20134.","journal-title":"Nature"},{"issue":"4","key":"3364_CR110","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/hep.27250","volume":"60","author":"K John","year":"2014","unstructured":"John K, et al. MicroRNAs play a role in spontaneous recovery from acute liver failure. Hepatology. 2014;60(4):1346\u201355.","journal-title":"Hepatology"},{"issue":"4","key":"3364_CR111","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jhep.2018.12.016","volume":"70","author":"H-C Tsay","year":"2019","unstructured":"Tsay H-C, et al. Hepatocyte-specific suppression of microRNA-221-3p mitigates liver fibrosis. J Hepatol. 2019;70(4):722\u201334.","journal-title":"J Hepatol"},{"issue":"10","key":"3364_CR112","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1111\/jcmm.13170","volume":"21","author":"Y Qu","year":"2017","unstructured":"Qu Y, et al. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation. J Cell Mol Med. 2017;21(10):2491\u2013502.","journal-title":"J Cell Mol Med"},{"key":"3364_CR113","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ebiom.2018.08.054","volume":"36","author":"Y Liu","year":"2018","unstructured":"Liu Y, et al. AMSC-derived exosomes alleviate lipopolysaccharide\/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP\/NLRP3 inflammasome activation in macrophages. EBioMedicine. 2018;36:140\u201350.","journal-title":"EBioMedicine"},{"issue":"11","key":"3364_CR114","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1111\/jcmm.13208","volume":"21","author":"G Lou","year":"2017","unstructured":"Lou G, et al. MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis. J Cell Mol Med. 2017;21(11):2963\u201373.","journal-title":"J Cell Mol Med"},{"issue":"14","key":"3364_CR115","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00018-020-03454-6","volume":"77","author":"X-L Fan","year":"2020","unstructured":"Fan X-L, et al. Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cell Mol Life Sci. 2020;77(14):2771\u201394.","journal-title":"Cell Mol Life Sci"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03364-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-023-03364-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03364-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T13:08:46Z","timestamp":1684933726000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-023-03364-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3364"],"URL":"https:\/\/doi.org\/10.1186\/s13287-023-03364-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]},"assertion":[{"value":"14 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}